C-Reactive Protein as a Predictor of Stem Cell Transplant Complications

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
CancerLeukemiaStem Cell Transplantation
Interventions
BEHAVIORAL

C-Reactive Protein levels

"Each patient enrolled in the study will have a serum quantitative c-reactive protein (crp) level drawn on the day of transplant, day 7 of transplant, and twice weekly after that until recovery of neutrophil count (approximately 20-25 days). Patients will be followed for 100 days post-transplant for the development of the following complications:~1. Sepsis- defined as fever, positive blood culture, need for fluid resuscitation and/or pressor support.~2. Acute GVHD \> grade II defined according to the Seattle criteria~3. VOD- defined according to the modified Seattle criteria"

Trial Locations (1)

60614

Children's Memorial Hospital, Chicago

All Listed Sponsors
lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT00179868 - C-Reactive Protein as a Predictor of Stem Cell Transplant Complications | Biotech Hunter | Biotech Hunter